Today: 2 February 2026
Subscribe
Browse Category

NASDAQ:IDYA News 2 February 2026

IDEAYA Biosciences stock jumps as February Citi, Evercore fireside chats near

IDEAYA Biosciences stock jumps as February Citi, Evercore fireside chats near

New York, Feb 2, 2026, 13:20 ET — Regular session Shares of IDEAYA Biosciences climbed about 5% on Monday, lifted by a broad upswing in biotech stocks. Investors zeroed in on the company ahead of two executive presentations scheduled for February. IDEAYA is heading into a stretch where investors expect clearer updates on clinical milestones. The stock often moves decisively…
2 February 2026
····

Stock Market Today

  • Goldman Sachs and Broadcom Gain Investor Interest on Deal Wins and Chip Potential
    February 2, 2026, 5:03 PM EST. Investors show renewed interest in Goldman Sachs and Broadcom. Goldman Sachs was named financial advisor for Coterra's $58 billion all-stock merger with Devon, the largest energy deal since 2024, bolstering its investment banking revenue, which made up 15% last year. The stock has risen 7.6% year-to-date, outpacing the S&P 500. Meanwhile, Broadcom shares are down nearly 20% from December highs but draw a buy rating from Mizuho, citing increased earnings from custom chip orders, including a potential $10-$15 billion client, Meta Platforms. Broadcom also supports Google's tensor processing units, with expected price hikes boosting profitability. Broadcom holds a 2 (hold) rating from Cramer's club with a $425 price target. Goldman Sachs maintains a 2 rating with a $1,050 target, favored for potential rebound amid increased mergers and acquisitions activity.
Go toTop